Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty
Clinical trial NCT05203705 · TERMINATED
Trial details
- NCT number
- NCT05203705
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2023-03-14
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.